000 01222 a2200313 4500
005 20250518000630.0
264 0 _c20190103
008 201901s 0 0 eng d
022 _a1558-1950
024 7 _a10.1016/j.giec.2018.05.007
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLeerhøy, Bonna
245 0 0 _aHow to Avoid Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
_h[electronic resource]
260 _bGastrointestinal endoscopy clinics of North America
_cOct 2018
300 _a439-454 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdministration, Rectal
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xadministration & dosage
650 0 4 _aCholangiopancreatography, Endoscopic Retrograde
_xadverse effects
650 0 4 _aHumans
650 0 4 _aPancreatitis
_xetiology
650 0 4 _aPatient Selection
650 0 4 _aRinger's Lactate
_xtherapeutic use
650 0 4 _aRisk Assessment
650 0 4 _aStents
700 1 _aElmunzer, B Joseph
773 0 _tGastrointestinal endoscopy clinics of North America
_gvol. 28
_gno. 4
_gp. 439-454
856 4 0 _uhttps://doi.org/10.1016/j.giec.2018.05.007
_zAvailable from publisher's website
999 _c28861309
_d28861309